IBDEI2L3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43342,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,43343,0)
 ;;=Z83.79^^197^2185^8
 ;;^UTILITY(U,$J,358.3,43343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43343,1,3,0)
 ;;=3^Family Hx of Digestive System Diseases
 ;;^UTILITY(U,$J,358.3,43343,1,4,0)
 ;;=4^Z83.79
 ;;^UTILITY(U,$J,358.3,43343,2)
 ;;=^5063387
 ;;^UTILITY(U,$J,358.3,43344,0)
 ;;=Z79.1^^197^2186^3
 ;;^UTILITY(U,$J,358.3,43344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43344,1,3,0)
 ;;=3^Long Term Current Use of NSAID
 ;;^UTILITY(U,$J,358.3,43344,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,43344,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,43345,0)
 ;;=Z79.52^^197^2186^5
 ;;^UTILITY(U,$J,358.3,43345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43345,1,3,0)
 ;;=3^Long Term Current Use of Systemic Steroids
 ;;^UTILITY(U,$J,358.3,43345,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,43345,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,43346,0)
 ;;=Z79.82^^197^2186^2
 ;;^UTILITY(U,$J,358.3,43346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43346,1,3,0)
 ;;=3^Long Term Current Use of Aspirin
 ;;^UTILITY(U,$J,358.3,43346,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,43346,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,43347,0)
 ;;=Z79.810^^197^2186^4
 ;;^UTILITY(U,$J,358.3,43347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43347,1,3,0)
 ;;=3^Long Term Current Use of SERMs
 ;;^UTILITY(U,$J,358.3,43347,1,4,0)
 ;;=4^Z79.810
 ;;^UTILITY(U,$J,358.3,43347,2)
 ;;=^5063337
 ;;^UTILITY(U,$J,358.3,43348,0)
 ;;=Z79.811^^197^2186^1
 ;;^UTILITY(U,$J,358.3,43348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43348,1,3,0)
 ;;=3^Long Term Current Use of Aromatase Inhibitors
 ;;^UTILITY(U,$J,358.3,43348,1,4,0)
 ;;=4^Z79.811
 ;;^UTILITY(U,$J,358.3,43348,2)
 ;;=^5063338
 ;;^UTILITY(U,$J,358.3,43349,0)
 ;;=E78.5^^197^2187^5
 ;;^UTILITY(U,$J,358.3,43349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43349,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,43349,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,43349,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,43350,0)
 ;;=E66.9^^197^2187^8
 ;;^UTILITY(U,$J,358.3,43350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43350,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,43350,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,43350,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,43351,0)
 ;;=E66.01^^197^2187^7
 ;;^UTILITY(U,$J,358.3,43351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43351,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,43351,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,43351,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,43352,0)
 ;;=E66.3^^197^2187^10
 ;;^UTILITY(U,$J,358.3,43352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43352,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,43352,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,43352,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,43353,0)
 ;;=I10.^^197^2187^6
 ;;^UTILITY(U,$J,358.3,43353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43353,1,3,0)
 ;;=3^Hypertension,Essential Primary
 ;;^UTILITY(U,$J,358.3,43353,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,43353,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,43354,0)
 ;;=I25.2^^197^2187^9
 ;;^UTILITY(U,$J,358.3,43354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43354,1,3,0)
 ;;=3^Old Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,43354,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,43354,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,43355,0)
 ;;=I25.10^^197^2187^2
 ;;^UTILITY(U,$J,358.3,43355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43355,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery,w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,43355,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,43355,2)
 ;;=^5007107
